| |
| |
|
| Insider
Information: |
Read Simon |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ra Pharmaceuticals, Inc. |
RARX |
Chief Scientific Officer |
2020-04-02 |
0 |
2019-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$604,560 |
D/D |
(12,595) |
0 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-12-17 |
4 |
AS |
$47.08 |
$470,821 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-12-17 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-11-14 |
4 |
AS |
$46.68 |
$466,808 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-11-14 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-10-16 |
4 |
AS |
$46.87 |
$468,726 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-10-16 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-09-12 |
4 |
AS |
$25.41 |
$254,050 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-09-12 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-08-23 |
4 |
AS |
$27.77 |
$277,703 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-08-23 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-07-17 |
4 |
AS |
$32.95 |
$329,479 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-07-17 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-06-18 |
4 |
AS |
$22.21 |
$222,467 |
D/D |
(10,000) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-06-18 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-02-01 |
4 |
D |
$21.00 |
$61,593 |
D/D |
(2,933) |
6,234 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Scientific Officer |
• – – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,167 |
9,167 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
